
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ANGO market cap is 375.93M. The company's latest EPS is USD -4.5557 and P/E is -2.04.
Quarter End | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 | Nov 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 79.07M | 75.18M | 70.98M | 67.49M | 72.85M |
Operating Income | -12.9M | -206.44M | -14.22M | -13.02M | -10.94M |
Net Income | -29.05M | -187.74M | -13.45M | -12.8M | -10.74M |
Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 275.69M | 291.01M | 316.22M | 338.75M | 303.91M |
Operating Income | -167.1M | -35.28M | -28.47M | -51.18M | -246.5M |
Net Income | -166.79M | -31.55M | -26.55M | -52.44M | -184.35M |
Quarter End | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 | Nov 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 499.62M | 324.84M | 317.67M | 293.63M | 291.55M |
Total Liabilities | 98.4M | 106.14M | 112.09M | 97.05M | 104.78M |
Total Equity | 401.23M | 218.7M | 205.59M | 196.58M | 186.77M |
Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 594.21M | 561.44M | 552.75M | 532.64M | 317.67M |
Total Liabilities | 139.34M | 121.98M | 128.26M | 154.34M | 112.09M |
Total Equity | 454.87M | 439.46M | 424.49M | 378.3M | 205.59M |
Quarter End | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 | Nov 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -20.63M | -33.16M | -28.16M | -18.25M | -15.78M |
Investing | 96.65M | 126.05M | 123.72M | -2.41M | -4.37M |
Financing | -59.94M | -59.25M | -64.25M | -509k | -1.63M |
Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -14.55M | 24.09M | -7.19M | 78k | -28.16M |
Investing | -63.35M | -13.71M | -19.31M | -9.75M | 123.72M |
Financing | -95.24M | -16.99M | 7.68M | 25.42M | -64.25M |
Market Cap | 375.93M |
Price to Earnings Ratio | -2.04 |
Price to Sales Ratio | 1.24 |
Price to Cash Ratio | 4.94 |
Price to Book Ratio | 1.83 |
Dividend Yield | - |
Shares Outstanding | 40.47M |
Average Volume (1 week) | 642.46k |
Average Volume (1 Month) | 503.82k |
52 Week Change | 55.61% |
52 Week High | 13.50 |
52 Week Low | 5.26 |
Spread (Intraday) | 1.48 (14.38%) |
Company Name | AngioDynamics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.angiodynamics.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions